Porsolt is known for its "Scientist-to-Scientist" approach.
Porsolt, a long-established, AAALAC-accredited, and fully GLP-compliant preclinical CRO, has been providing efficacy and safety pharmacology services for over 35 years, covering the drug development process from early screening to regulatory studies before first-in-man administration, including predictive toxicology, full assessment of cardiac risk, and abuse and dependence liability. Porsolt works with pharmaceutical and biotechnology companies, academic institutes, and not-for-profit organizations, offering specialized preclinical testing services across many disease areas, physiological systems and processes. Porsolt provides services in vitro and in vivo discovery, screening, efficacy and safety pharmacology using standardized and innovative techniques. For additional information about the organization, please visit www.porsolt.com or email us at contact@porsolt.com